CEO and cofounder at Advanced Brain Monitoring.
Challenges in Early Diagnosis of Frontotemporal Dementia in Clinical Settings: Chris Berka
August 13th 2024The CEO and cofounder at Advanced Brain Monitoring talked about how the early diagnosis of frontotemporal dementia is often mistaken for Alzheimer disease, but advancements in neuropsychological assessments and biomarker identification may improve accuracy. [WATCH TIME: 4 minutes]
Tracking Neurodegenerative Disease Trajectories With EEG Biomarkers: Chris Berka
August 11th 2024The CEO and cofounder at Advanced Brain Monitoring discussed using EEG-based biomarkers to identify early markers that predict cognitive decline and aid in differential diagnosis for neurodegenerative diseases. [WATCH TIME: 4 minutes]
Insights From a Large-Scale Study on Differentiating Dementia Subtypes With EEG: Chris Berka
August 8th 2024The CEO and cofounder at Advanced Brain Monitoring talked about how exploring electroencephalography patterns can help differentiate between Alzheimer disease, Lewy body dementia, and frontotemporal dementia. [WATCH TIME: 3 minutes]